The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways
Open accessAbstract
BACKGROUND AND AIMS: Short chain fatty acids (SCFA) exert profound effects on the colonic mucosa. In particular, SCFA modulate mucosal immune functions. The antimicrobial cathelicidin LL-37 is expressed by colon epithelial cells. In the present study the effect of SCFA on LL-37 expression was investigated. METHODS: LL-37 expression in vivo was assessed by immunohistochemistry. Real time quantitative reverse transcription-polymerase chain reaction was employed to determine LL-37 expression in colonocytes in vitro after treatment with various cytokines, SCFA, or flavone. LL-37 levels were correlated to cell differentiation which was determined by alkaline phosphatase (AP) activity. In addition, intracellular signalling pathways such as MEK-ERK (mitogen/extracellular signal protein kinase (MEK)/extracellular signal regulated protein kinase (ERK)) and p38/mitogen activated protein (MAP) kinase were explored. RESULTS: In vivo, LL-37 expression in healthy mucosa was restricted to differentiated epithelial cells in human colon and ileum. In colonocytes, increased LL-37 expression associated with cell differentiation was detected in vitro following treatment with butyrate, isobutyrate, propionate, and trichostatin A. Flavone induced LL-37 transcription but did not affect AP activity while cytokines had no effect. To dissect pathways mediating differentiation and LL-37 expression, specific inhibitors were applied. Inhibition of the protein kinase MEK enhanced butyrate induced AP activity while LL-37 expression in colon epithelial cells was blocked. In contrast, inhibition of p38/MAP kinase blocked cell differentiation without inhibiting LL-37 expression. CONCLUSIONS: Expression of the cathelicidin LL-37 in colonocytes and cellular differentiation are separately modulated by SCFA via distinct signalling pathways. These data may provide a rationale for dietary modulation of mucosal defence mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“microbial metabolites are integral for promoting immune responses in the gut against pathogens, including inducing secretion of IL-18 (36) and defensins (37, 38)”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J. ‐. (1997) · Nature · doi:10.1038/43088 · Cited by 1,365
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., ZASLOFF, M. A., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,077
Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., López-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., & Parks, W. C. (1999) · Science · doi:10.1126/science.286.5437.113 · Cited by 1,076
Frohm, M., Agerberth, B., Ahangari, G., Ståhle‐Bäckdahl, M., Lidén, S., Wigzell, H., & Gudmundsson, G. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15258 · Cited by 803
Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Effects of short chain fatty acids on gut morphology and function
Scheppach, W. (1994) · Gut · doi:10.1136/gut.35.1_suppl.s35 · Cited by 756
Bals, R., Wang, X., ZASLOFF, M. A., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 745
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis
Scheppach, W. M., Sommer, H., Kirchner, T., Paganelli, G.-M., Bartram, P., Christl, S. U., Richter, F., Dusel, G., & Kasper, H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91094-k · Cited by 740
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3718 · Cited by 662
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Regulation of immune cell function by short‐chain fatty acids
Corrêa‐Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T., & Vinolo, M. A. R. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.17 · Cited by 1,346
Butyrate: A Double-Edged Sword for Health?
Liu, H., Wang, J., He, T., Becker, S. R., Zhang, G., Li, D., & Ma, X. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx009 · Cited by 1,185
Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3284com · Cited by 1,145
Diet, microorganisms and their metabolites, and colon cancer
O'Keefe, S. J. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.165 · Cited by 1,100
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature reviews. Immunology · doi:10.1038/nri3228 · Cited by 1,020
Gut Microbial Metabolites Fuel Host Antibody Responses
Kim, M., Qie, Y., Park, J., & Kim, C. H. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.001 · Cited by 893
“SCFAs support epithelial cell integrity, innate immune functions, and the generation of regulatory and effector T cells (Arpaia et al., 2013; Furusawa et al., 2013; Kim et al., 2013; Park et al., 2015; Sakata, 1987; Schauber et al., 2003).”
BackgroundThe Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 916
Probiotic bacteria and intestinal epithelial barrier function
Ohland, C., & MacNaughton, W. K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00243.2009 · Cited by 832
An update on alternatives to antimicrobial growth promoters for broilers
Huyghebaert, G., Ducatelle, R., & Immerseel, F. V. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.03.003 · Cited by 820
Neutrophil granules: a library of innate immunity proteins
Borregaard, N., Sørensen, O. E., & Theilgaard‐Mönch, K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.06.002 · Cited by 735
Systematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Bals, R., & Hiemstra, P. S. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00098803 · Cited by 589
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Liévin-Le Moal, V., & Servin, A. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.315-337.2006 · Cited by 568
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Reyes, S. O. L., & Teran, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 571
Zhao, Y., Chen, F., Wu, W. H., Sun, M., Bilotta, A. J., Yao, S., Xiao, Y., Huang, X., Eaves-Pyles, T. D., Golovko, G., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.118 · Cited by 536
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02640 · Cited by 495
Wang, J., Ji, H., Wang, S., Liu, H., Zhang, W., Zhang, D., & Wang, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01953 · Cited by 463
The Vitamin D–Antimicrobial Peptide Pathway and its Role in Protection Against Infection
Gombart, A. F. (2009) · Future Microbiology · doi:10.2217/fmb.09.87 · Cited by 474
Hodgkinson, K. M., Abbar, F. E., Dobranowski, P., Manoogian, J., Butcher, J., Figeys, D., Mack, D. R., & Stintzi, A. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.10.024 · Cited by 465
Singh, A. K., Cabral, C., Kumar, R., Ganguly, R., Rana, H. K., Gupta, A., Lauro, M. R., Carbone, C., Reis, F., & Pandey, A. K. (2019) · Nutrients · doi:10.3390/nu11092216 · Cited by 454
Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier
Liu, Q., Yu, Z., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-1289-4 · Cited by 456
The epigenetic effects of butyrate: potential therapeutic implications for clinical practice
Berni Canani, R., Di Costanzo, M., & Leone, L. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-4 · Cited by 431
Wound healing in the 21st century
Schreml, S., Szeimies, R., Prantl, L., Landthaler, M., & Babilas, P. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.10.048 · Cited by 433
The Role of Cathelicidins in the Innate Host Defenses of Mammals
Zanetti, M. (2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.179 · Cited by 414
Immune regulation by microbiome metabolites
Kim, C. H. (2018) · Immunology · doi:10.1111/imm.12930 · Cited by 375
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 376
Malla, M. A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., & Allah, E. F. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02868 · Cited by 366
d’Enfert, C., Kaune, A.-K., Alaban, L. R., Chakraborty, S., Cole, N. L., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 377
Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3
Yim, S., Dhawan, P., Ragunath, C., Christakos, S., & Diamond, G. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.03.003 · Cited by 347
Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis
Wu, S., Zhang, Y., Lu, R., Xia, Y., Zhou, D., Petrof, E. O., Claud, E. C., Chen, D., Chang, E. B., Carmeliet, G., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307436 · Cited by 353
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Xu, J., Chen, H., & Li, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21431 · Cited by 346
Murphy, D., Ricci, A., Auce, Z., Beechinor, J. G., Bergendahl, H., Breathnach, R., Bureš, J., Silva, J. P. D. D., Hederová, J., Hekman, P., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4666 · Cited by 348
Raqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., Islam, K., Gudmundsson, G. H., Andersson, J., & Agerberth, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602888103 · Cited by 317
Sun, J., Furio, L., Mecheri, R., van der Does, A. M., Lundeberg, E., Saveanu, L., Chen, Y., van Endert, P., Agerberth, B., & Diana, J. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.013 · Cited by 292
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. W. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 290
(2016) · PubMed · Cited by 287
Sunkara, L. T., Achanta, M., Schreiber, N. B., Bommineni, Y. R., Dai, G., Jiang, W., Lamont, S. J., Lillehoj, H. S., Beker, A., Teeter, R. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027225 · Cited by 283
The impact of the pH value on skin integrity and cutaneous wound healing
Schreml, S., Szeimies, R., Karrer, S., Heinlin, J., Landthaler, M., & Babilas, P. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03413.x · Cited by 279
Ma, N., & Ma, X. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12401 · Cited by 285
Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology
Priyadarshini, M., Kumar, K. U., Dudeja, P. K., & Layden, B. T. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170050 · Cited by 284
Schauber, J., Dorschner, R. A., Yamasaki, K., Brouha, B., & Gallo, R. L. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02399.x · Cited by 270
Self-citationNutrition meets the microbiome: micronutrients and the microbiota
Biesalski, H. K. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13145 · Cited by 265
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 264
The butyrate story: old wine in new bottles?
Scheppach, W. M., & Weiler, F. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200409000-00009 · Cited by 246
Hoefs, S., Mogavero, S., & Hube, B. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5514-0 · Cited by 251
Duan, H., Wang, L., Huangfu, M., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115276 · Cited by 252
Antimicrobial Peptides, Innate Immunity, and the Normally Sterile Urinary Tract
ZASLOFF, M. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050611 · Cited by 230
Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094494 · Cited by 202
Timbermont, L., Lanckriet, A., Dewulf, J., Nollet, N., Schwarzer, K., Haesebrouck, F., Ducatelle, R., & Immerseel, F. V. (2010) · Avian Pathology · doi:10.1080/03079451003610586 · Cited by 201
Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis
Luo, M., Liu, Y., Wu, P., Luo, D., Sun, Q., Han, Z., Hu, R., Pandol, S. J., Li, Q., Han, Y., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00822 · Cited by 194
Bacteria in the Intestine, Helpful Residents or Enemies from Within?
Canny, G., & McCormick, B. A. (2008) · Infection and Immunity · doi:10.1128/iai.00187-08 · Cited by 189
The role of the intestinal microbiota in enteric infection
Sekirov, I., & Finlay, B. B. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172742 · Cited by 188
The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
Chen, J., & Vitetta, L. (2020) · Immune Network · doi:10.4110/in.2020.20.e15 · Cited by 196
Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats
Iacob, S. A., Iacob, D. G., & Luminos, L. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03328 · Cited by 191
Antibiotic-Induced Disruption of Gut Microbiota Alters Local Metabolomes and Immune Responses
Sun, L., Zhang, X., Zhang, Y., Zheng, K., Xiang, Q., Chen, N., Chen, Z., Zhang, N., Zhu, J., & He, Q. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00099 · Cited by 186
Mily, A., Rekha, R. S., Kamal, S. M. M., Arifuzzaman, A. S. M., Rahim, Z., Khan, L., Haq, M. A., Zaman, K., Bergman, P., Brighenti, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138340 · Cited by 185
Intestinal health functions of colonic microbial metabolites: a review
Havenaar, R. (2011) · Beneficial Microbes · doi:10.3920/bm2011.0003 · Cited by 185
Rekha, R. S., Muvva, S. J. R., Wan, M., Raqib, R., Bergman, P., Brighenti, S., Gudmundsson, G. H., & Agerberth, B. (2015) · Autophagy · doi:10.1080/15548627.2015.1075110 · Cited by 183
Perić, M., Koglin, S., Kim, S.-M., Morizane, S., Besch, R., Prinz, J. C., Ruzicka, T., Gallo, R. L., & Schauber, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8504 · Cited by 178
Self-citationPhytochemicals as modifiers of gut microbial communities
Dingeo, G., Alex Brito, O., Samouda, H., Iddir, M., Frano, M. R. L., & Bohn, T. (2020) · Food & Function · doi:10.1039/d0fo01483d · Cited by 175
Defensins and other antimicrobial peptides in inflammatory bowel disease
Wehkamp, J., Schmid, M., & Stange, E. F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328136c580 · Cited by 167
Cathelicidins Modulate TLR-Activation and Inflammation
Scheenstra, M. R., van Harten, R. M., Veldhuizen, E. J. A., Haagsman, H. P., & Coorens, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01137 · Cited by 170
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Schauber, J., Rieger, D., Weiler, F., Wehkamp, J., Eck, M., Fellermann, K., Scheppach, W. M., Gallo, R. L., & Stange, E. F. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200606000-00007 · Cited by 169
Self-citationExpression and regulation of antimicrobial peptides in the gastrointestinal tract
Cunliffe, R., & Mahida, Y. R. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503249 · Cited by 163
Schauber, J., Oda, Y., Büchau, A. S., Yun, Q.-C., Steinmeyer, A., Zügel, U., Bikle, D. D., & Gallo, R. L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701102 · Cited by 164
Self-citationHost–microbe interactions shaping the gastrointestinal environment
Kaiko, G. E., & Stappenbeck, T. S. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.08.002 · Cited by 155
Developmental switch of intestinal antimicrobial peptide expression
Ménard, S., Förster, V., Lotz, M., Gütle, D., Duerr, C. U., Gallo, R. L., Henriques‐Normark, B., Pütsep, K., Andersson, M., Glocker, E. O., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071022 · Cited by 151
Physiology and central carbon metabolism of the gut bacterium Prevotella copri
Franke, T., & Deppenmeier, U. (2018) · Molecular Microbiology · doi:10.1111/mmi.14058 · Cited by 155
Butyrate production in phylogenetically diverse Firmicutes isolated from the chicken caecum
Eeckhaut, V., Immerseel, F. V., Croubels, S., Baere, S. D., Haesebrouck, F., Ducatelle, R., Louis, P., & Vandamme, P. A. R. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00244.x · Cited by 143
The microbiome–systemic diseases connection
van der Meulen, T. A., Harmsen, H., Bootsma, H., Spijkervet, F., Kroese, F., & Vissink, A. (2016) · Oral Diseases · doi:10.1111/odi.12472 · Cited by 144
Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis
Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X.-B., Mandal, K., Xu, Q., & Yan, Z. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223901.08459.57 · Cited by 147
Antimicrobial peptides in the first line defence of human colon mucosa
Tollin, M., Bergman, P., Svenberg, T., Jörnvall, H., Gudmundsson, G. H., & Agerberth, B. (2003) · Peptides · doi:10.1016/s0196-9781(03)00114-1 · Cited by 141
Modulation of Antimicrobial Host Defense Peptide Gene Expression by Free Fatty Acids
Sunkara, L. T., Jiang, W., & Zhang, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049558 · Cited by 140
Regulation of the Intestinal Barrier Function by Host Defense Peptides
Robinson, K., Deng, Z., Hou, Y., & Zhang, G. (2015) · Frontiers in Veterinary Science · doi:10.3389/fvets.2015.00057 · Cited by 145
Gut Microbiome as Target for Innovative Strategies Against Food Allergy
Canani, R. B., Paparo, L., Nocerino, R., Scala, C. D., Gatta, G. D., Maddalena, Y., Buono, A., Bruno, C., Voto, L., & Ercolini, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00191 · Cited by 145
The Impact of Lactoferrin on the Growth of Intestinal Inhabitant Bacteria
Vega-Bautista, A., de la Garza, M., Carrero, J. C., Campos‐Rodríguez, R., Godínez‐Victoria, M., & Drago-Serrano, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194707 · Cited by 140
Phenylbutyrate Induces Antimicrobial Peptide Expression
Steinmann, J., Halldórsson, S., Agerberth, B., & Gudmundsson, G. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00818-09 · Cited by 140
Xiong, H., Guo, B., Gan, Z.-S., Song, D., Lu, Z., Yi, H., Wu, Y., Wang, Y., & Du, H. (2016) · Scientific Reports · doi:10.1038/srep27070 · Cited by 139
Zeng, X., Sunkara, L. T., Jiang, W., Bible, M., Carter, S., Ma, X., Qiao, S., & Zhang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072922 · Cited by 137
Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice
Koon, H. W., Shih, D. Q., Chen, J., Bakirtzi, K., Hing, T. C., Law, I. K. M., Ho, S., Ichikawa, R., Zhao, D., Xu, H. J., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.079 · Cited by 136
Wu, W. K. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, C. W., Fan, D., Wu, K., Yu, J. Q., Sung, J. J. �., & Cho, C. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25489 · Cited by 136
Microbial signature in IgE-mediated food allergies
Goldberg, M. R., Mor, H., Neriya, D. M., Magzal, F., Muller, E., Appel, M. Y., Nachshon, L., Borenstein, E., Tamir, S., Louzoun, Y., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00789-4 · Cited by 139
Gombart, A. F., Saito, T., & Koeffler, H. P. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-321 · Cited by 131
Nardo, A. D., Yamasaki, K., Dorschner, R. A., Lai, Y., & Gallo, R. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7565 · Cited by 130
Avian Antimicrobial Host Defense Peptides: From Biology to Therapeutic Applications
Zhang, G., & Sunkara, L. T. (2014) · Pharmaceuticals · doi:10.3390/ph7030220 · Cited by 131
Cederlund, A., Kai-Larsen, Y., Printz, G., Yoshio, H., Alvélius, G., Lagercrantz, H., Strömberg, R., Jörnvall, H., Gudmundsson, G. H., & Agerberth, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053876 · Cited by 129
Defensins and cathelicidins in gastrointestinal infections
Wehkamp, J., Schauber, J., & Stange, E. F. (2006) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801182c2 · Cited by 127
Self-citationAntimicrobial peptides: Role in human disease and potential as immunotherapies
de la Fuente‐Núñez, C., Silva, O. N., Lu, T. K., & Franco, O. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.04.002 · Cited by 127
Epigenetic regulation in bacterial infections: targeting histone deacetylases
Grabiec, A. M., & Potempa, J. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1373063 · Cited by 119
Vitamin D and microbiota: Two sides of the same coin in the immunomodulatory aspects
Malaguarnera, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106112 · Cited by 120
The vitamin D pathway: a new target for control of the skin’s immune response?
Schauber, J., & Gallo, R. L. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00768.x · Cited by 121
Self-citationNeisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37
Bergman, P., Johansson, L., Asp, V., Plant, L., Gudmundsson, G. H., Jonsson, A., & Agerberth, B. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00530.x · Cited by 118
Kida, Y., SHIMIZU, T., & Kuwano, K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.014 · Cited by 118
Metadata
- Authors
- Schauber, J.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Schauber, J
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-05-01
- Volume
- 52
- Issue
- 5
- Pages
- 735-741
- ISSN
- 0017-5749 (ISSN-L)
- PMC
- PMC1773650
- OpenAlex
- W2130246343
- Cited by
- 383
- References
- 41
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 15 · 2023: 21 · 2022: 27 · 2021: 15 · 2020: 24 · 2019: 25 · 2018: 23 · 2017: 17 · 2016: 21 · 2015: 12 · 2014: 20 · 2013: 17 · 2012: 19
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Boehringer Ingelheim Fonds
- Deutsche Forschungsgemeinschaft
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Julius-Maximilians-Universität Würzburg
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- cathelicidin LL-37, short-chain fatty acids, colonic epithelial cells, butyrate, MEK/ERK signaling, p38 MAPK, flavones, alkaline phosphatase activity, mucosal immunity
- MeSH terms
- Adult, Alkaline Phosphatase, Biopsy, Butyrates, Cell Differentiation, Cell Line, Colon, Epithelial Cells, Fatty Acids, Volatile, Flavonoids, Humans, Hydroxamic Acids, Immunohistochemistry, Intestinal Mucosa, Protein Kinases, Protein Synthesis Inhibitors, Signal Transduction, Apoptosis, Reverse Transcriptase Polymerase Chain Reaction, Antimicrobial Cationic Peptides, Flavones, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review